Coronary artery disease (CAD) is a cardiovascular disease of the blood vessels that makes
vessels, narrow and hardened and difficult to supply blood to the heart. The epidemiology of …

Aims Although a true clinical challenge, high bleeding risk patients with an acute coronary
syndrome (ACS) undergoing percutaneous coronary intervention (PCI) have never been …

Dual antiplatelet therapy (DAPT) is currently the standard of care after percutaneous
coronary intervention (PCI). Recent studies suggest that reducing DAPT to 1-3 months …

Aims To investigate the 1-year risks of Staphylococcus aureus bacteraemia (SAB), sepsis,
and pneumonia in patients who underwent percutaneous coronary intervention and were …

Background: Stent-assisted coil (SAC) is increasingly used to treat unruptured intracranial
aneurysm (UIA). However, the optimal duration of dual-antiplatelet therapy (DAPT) after SAC …

Background: The management of acute myocardial infarction (AMI) presents several
challenges in patients with diabetes, among them the higher rate of recurrent thrombotic …

Background. Coronary artery disease (CAD) is common in lung transplant candidates and
may require revascularization before or at the time of their transplant. We reviewed the …

All patients having pulmonary resections should have a preoperative assessment of their
respiratory function in three areas: lung mechanical function, pulmonary parenchymal …

Background: Excess vascular deaths in the PLATO trial comparing ticagrelor to clopidogrel
have been repeatedly challenged by the Food and Drug Administration (FDA) reviewers and …

Abstract Background and Objective In patients with atrial fibrillation following percutaneous
coronary intervention, if a proton pump inhibitor is used, could that allow the use of warfarin …